Empagliflozin as an adjunctive therapy for type 1 diabetes

Ann Transl Med. 2018 Dec;6(Suppl 2):S134. doi: 10.21037/atm.2018.12.52.

Authors

Richard J MacIsaac^{1

2}, Melissa H Lee^{1

2}, Sybil A McAuley^{1

2}, Glenn M Ward^{1

2}, David N O'Neal^{1

2}

Affiliations

¹ Department of Endocrinology & Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia.
² Department of Medicine, University of Melbourne, Victoria, Australia.

No abstract available

Publication types

Editorial
Comment